Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cell death, therapeutics, and the immune response in cancer

Trends in cancer(2023)10.1016/j.trecan.2023.02.001Source: DataRank Database

Cell death, therapeutics, and the immune response in cancer is a research paper published in Trends in cancer (2023). On theSindex it has a DataRank of 0. It has been cited 227 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access227 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (15)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Brian Ruffell ORCID,Kay Hänggi ORCID

Live enrichment

PubMed:36841748 PMC:PMC10121860

NCI

Grant: R01CA230610

CDMRP

Grant: W81XWH-20-1-0012

CDMRP

Grant: W81XWH-22-1-0406

Cancer Research Institute

California Breast Cancer Research Program

National Institutes of Health

University of South Florida

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10121860/pdf/nihms-1872400.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000213?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000213?httpAccept=text/plain

MeSH Terms

HumansNeoplasmsCell DeathApoptosisImmunityPyroptosis

Keywords

ApoptosisImmunotherapyImmunogenicityCell deathTumor MicroenvironmentNecroptosisPyroptosisImmunogenic Cell DeathFerroptosis

Additional file 1 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650284.v1figshare

Additional file 1 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650284figshare

Additional file 1 of Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis

10.6084/m9.figshare.26716270.v1figshare

Additional file 1 of Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis

10.6084/m9.figshare.26716270figshare

Additional file 2 of Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma

10.6084/m9.figshare.26659453figshare

Additional file 2 of Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma

10.6084/m9.figshare.26659453.v1figshare

Additional file 1 of Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma

10.6084/m9.figshare.26659450figshare

Additional file 1 of Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma

10.6084/m9.figshare.26659450.v1figshare

Additional file 4 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650293.v1figshare

Additional file 3 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650290.v1figshare

Additional file 2 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650287.v1figshare

Additional file 3 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650290figshare

Additional file 2 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

10.6084/m9.figshare.26650287figshare

Additional file 4 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma